« Previous
Next »
American Journal of Cardiology
Volume 103, Issue 6
, Pages
785-790
, 15 March 2009
Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)
To access this article, please choose from the options below
The FATA trial was a spontaneous, noncompany promoted study almost entirely funded by each participating center and from the Fondazione Fanti-Melloni, a charitable institution linked to the University of Bologna. The study was partially supported with a research grant by Merck & Co., Inc. The company had no role in the study design, the analysis and interpretation of the data, or the drafting or revision of the final manuscript.
PII: S0002-9149(08)02084-5
doi: 10.1016/j.amjcard.2008.11.029
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 103, Issue 6
, Pages
785-790
, 15 March 2009
